Nvidia Leads a Market-Moving Mix of Tech and Biotech Stocks

Nvidia rose about 4% after earnings, with its outlook signaling roughly 70% revenue growth next year, while Abercrombie jumped ~36% on upbeat Q2 results and outlook; Revolution Medicines gained after FDA approval for a daily pancreatic cancer pill, and Apple moved higher ahead of its Sept. 9 iPhone event. Meta Platforms agreed to pay up to $18 billion to settle a multi-state lawsuit, Intuit slipped on a softer revenue forecast, and Zoom fell despite solid earnings as investors digested inflation data and Nvidia’s results in a mixed market.